| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 7e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 9e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |